Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Craig Johnson | M | 62 | 10 years | |
| Trafford Clarke | M | 66 | 2 years | |
| Sean T. Ristine | M | 54 | 10 years |
See more
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John W. Poyhonen | M | 64 | 9 years | |
| John B. Whelan | M | 62 | 4 years | |
| Kimberly Manhard | F | 64 | 9 years | |
| Brian Drazba | M | 63 | 4 years | |
| Peter Atadja | M | 64 | 2 years | |
| Esmé c. Smith | F | 52 | - | |
| Michael Brooks | M | 50 | 2 years | |
| Jesse Hollingsworth | M | - | - | |
| Steve Innaimo | M | - | 1 years | |
| Lisa Peraza | F | 47 | 10 years | |
| Xiao Ning Guo | M | 46 | 4 years | |
| Adar Makovski Silverstein | M | - | 2 years | |
| Bob Dagher | M | 55 | 1 years | |
| Robert Aspbury | M | 53 | 18 years | |
| Paul Kirchgraber | M | 62 | - | |
| Erin O’Boyle | F | - | 8 years | |
| Matthew Hoffman | M | 47 | 1 years | |
| Paul Barone | M | - | - | |
| Joel Schaedler | M | - | - | |
| Abraham Noah Oler | M | 48 | 4 years | |
| Arlo McGinn | M | - |
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | - |
| Paul G. Marshall | M | 64 | 3 years | |
| Michael Saunders | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 26 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark Gelder
- Personal Network
